CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,051 | -31.8% | 154,310 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | -35.9% | 154,310 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $39,000 | -52.4% | 154,310 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $82,000 | -13.7% | 154,310 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $95,000 | -77.5% | 154,310 | -62.7% | 0.00% | -78.6% |
| Q3 2021 | $422,000 | -44.3% | 413,481 | 0.0% | 0.01% | -44.0% |
| Q2 2021 | $757,000 | -7.1% | 413,481 | 0.0% | 0.02% | -10.7% |
| Q1 2021 | $815,000 | +57.6% | 413,481 | 0.0% | 0.03% | +55.6% |
| Q4 2020 | $517,000 | -30.5% | 413,481 | 0.0% | 0.02% | -35.7% |
| Q3 2020 | $744,000 | -76.6% | 413,481 | +9.2% | 0.03% | -76.9% |
| Q2 2020 | $3,177,000 | – | 378,706 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |